BioAxone BioSciences

08/07/2018

Adult neurons in the CNS express proteins that are intrinsic barriers to recovery after neurotrauma. BioAxone is working to develop a drug compound that reduces expression of , a protein that blocks axon regeneration in adult neurons.

08/02/2018

SCI model systems are important centers that support innovative projects and research related to and provide services to meet the needs of individuals with SCI. See where they are located:
http://ow.ly/TiVx30kzeBm

07/26/2018

Dr. Eve Tsai, a neurosurgeon based in Ottawa Canada wrote a great article on current clinical development strategies to treat : http://ow.ly/v2Up30kylFS

06/19/2018

Did you know that in the 1930's Konrad Lorenz discovered that young geese become attached to their mothers within the first days after hatching? This is a social attachment that Lorenz called imprinting and the finding had a tremendous impact on our understanding of developmental psychology.

05/29/2018

So many drugs with potential, not enough NINDS Translate ElsevierNeuroscience That is why BioAxone bridges the gap with new and novel drug candidates.

03/08/2018

Today is International Women's Day. We are proud to be led by a woman CEO, Lisa McKerracher, as well as woman scientists, administrators, and consultants throughout the company. Let's all take time to recognize and appreciate the impact of women in our companies, communities, and our lives.

Via our friends at Massbio, here's a link to a number of great article addressing gender diversity in the drug and tech industries:

https://www.massbio.org/news/blog/international-women-s-day-pressforprogress-continues-141263

Join us as we !

02/28/2018

An estimated 12,500 spinal cord injuries occur every year. We are committed to finding a cure and our first-in-class product that promotes axon regeneration is in late-stage clinical trial. Our product is topically applied to the spinal cord in acute trauma surgery and is designed to help repair damaged circuits in the spinal cord. http://ow.ly/TpF330id4dk

02/26/2018

The anxiety of harboring a silent neurovascular disorder can be terrible - and lead to a hard choice - See stories on Boston-based WCVB Chronicle . http://ow.ly/ZxkB30id2tB. BioAxone is developing a drug to provide a non-surgical alternative for those with neurovascular disease.

Vanessa Garza felt like she had it all, but something was unsettling her: strange sounds she heard from time to time. When she went for a diagnosis, the results shocker her. She suffered from a rare brain condition that could be fatal.

02/22/2018

Quote of the day: "Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided" Paracelsus

02/19/2018

Great blog by Dr. Ed Smith Boston Children's describing "What parents need to know" about cavernous angioma http://ow.ly/aiyX30id4XD

02/16/2018

This video explains cavernous angioma from a patient's point of view. A must see! http://ow.ly/XyxM30id0fi Angioma Alliance

“A good story on paying attention to symptoms https://t.co/27Yp2RkxBo”

02/12/2018

Great review by BioAxone Research Scientist, Dr. Woller published a review on "Pathways encoding nociception"